| Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles S Imlimthan, A Correia, P Figueiredo, K Lintinen, V Balasubramanian, ... Journal of Biomedical Materials Research Part A 108 (3), 770-783, 2020 | 43 | 2020 |
| New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress S Imlimthan, ES Moon, H Rathke, A Afshar-Oromieh, F Rösch, ... Pharmaceuticals 14 (10), 1023, 2021 | 42 | 2021 |
| Radiolabeled molecular imaging probes for the in vivo evaluation of cellulose nanocrystals for biomedical applications S Imlimthan, S Otaru, O Keinanen, A Correia, K Lintinen, HA Santos, ... Biomacromolecules 20 (2), 674-683, 2018 | 41 | 2018 |
| A Theranostic Cellulose Nanocrystal-based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma S Imlimthan, YC Khng, OM Keinanen, W Zhang, A Airaksinen, ... Small, 2021 | 30 | 2021 |
| Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics D Lumen, S Wang, E Mäkilä, S Imlimthan, M Sarparanta, A Correia, ... European Journal of Pharmaceutics and Biopharmaceutics 158, 254-265, 2021 | 17 | 2021 |
| Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library … J Matovic, J Jarvinen, IK Sokka, S Imlimthan, JE Raitanen, A Montaser, ... Molecular Pharmaceutics 18 (1), 285-304, 2020 | 15 | 2020 |
| Addressing the Biochemical Foundations of a Glucose-Based “Trojan Horse”-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment J Matović, J Järvinen, HC Bland, IK Sokka, S Imlimthan, RM Ferrando, ... Molecular pharmaceutics 17 (10), 3885-3899, 2020 | 15 | 2020 |
| Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model D Lumen, S Näkki, S Imlimthan, E Lambidis, M Sarparanta, W Xu, ... Pharmaceutics 11 (12), 686, 2019 | 14 | 2019 |
| Development of [18F]AmBF3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [18F]AmBF3-PEG7-Tyr3-Octreotide in an … S Otaru, A Paulus, S Imlimthan, I Kuurne, H Virtanen, H Liljenbäck, ... Bioconjugate Chemistry 33 (7), 1393-1404, 2022 | 13 | 2022 |
| Evaluation of Organo [18F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers S Otaru, S Imlimthan, M Sarparanta, K Helariutta, K Wähälä, ... Molecules 25 (5), 1208, 2020 | 11 | 2020 |
| Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb U Jakobsson, E Mäkilä, A Rahikkala, S Imlimthan, J Lampuoti, S Ranjan, ... Nuclear Medicine and Biology 84, 102-110, 2020 | 9 | 2020 |
| Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [89Zr]Zr-DFO-PEG5-Tz D Lumen, D Vugts, M Chomet, S Imlimthan, M Sarparanta, R Vos, ... Bioconjugate chemistry 33 (5), 956-968, 2022 | 6 | 2022 |
| Introduction to lignocellulosic materials S Imlimthan, P Figueiredo, H Santos, M Sarparanta Lignin-based materials for biomedical applications 1, 1-33, 2021 | 5 | 2021 |
| Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter J Matovic, J Jarvinen, IK Sokka, P Stockmann, M Kellert, S Imlimthan, ... ACS omega 7 (34), 30376-30388, 2022 | 4 | 2022 |
| Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: comparison of pharmacokinetics E Lambidis, D Lumén, E Koskipahta, S Imlimthan, BB Lopez, AIF Sánchez, ... Nuclear Medicine and Biology 114, 151-161, 2022 | 3 | 2022 |
| Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET E Lambidis, CC Chen, M Baikoghli, S Imlimthan, YC Khng, M Sarparanta, ... Molecular pharmaceutics 19 (8), 2971-2979, 2022 | 3 | 2022 |
| Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature A Escudero-Castellanos, J Kurth, S Imlimthan, E Menéndez, E Pilatis, ... European journal of nuclear medicine and molecular imaging 50 (11), 3202-3213, 2023 | 2 | 2023 |
| Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity IK Sokka, S Imlimthan, M Sarparanta, H Maaheimo, MP Johanssan, ... Molecular Pharmaceutics, 2021 | 2 | 2021 |
| Radiolabeling of Theranostic Nanosystems S Das, S Imlimthan, A Airaksinen, M Sarparanta Bio-Nanomedicine for Cancer Therapy 1295, 49-76, 2021 | 2 | 2021 |
| A side-by-side comparison of a monomer- versus a dimer-based 68Ga- and 177Lu-labeled FAP inhibitor for theranostic tumor stroma targeting T Lappchen, E Pilatis, E Menendez, S Imlimthan, ES Moon, F Roesch, ... NUCLEAR MEDICINE AND BIOLOGY 126, S59-S59, 2023 | | 2023 |
Anu AiraksinenProfessor, Radiochemistry, Turku PET Centre/University of Turku, FinlandVerified email at utu.fi
